Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice

ConclusionsThis TTFields safety surveillance analysis in>  11,000 patients revealed no new safety concerns, with a favorable safety profile comparable with published TTFields/GBM trials. The safety profile remained consistent among subgroups, suggesting feasibility in multiple populations, including elderly patients.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research